Sponsors

Bordetella pertussis infection: testing for the re-emergence of whooping cough

Despite the high vaccination coverage in developed countries, Bordetella pertussis infection is considered a re-emerging disease that is underreported and underdiagnosed. Here, Pathology in Practice Science Editor Brian Nation compiles a selection of research interest.

Microfluidic point-of-care testing for the detection of Bordetella pertussis: A mini-review

Yılmaz Çolak Ç. Diagn Microbiol Infect Dis. 2024 Jun; 109 (2): 116239. doi: 10.1016/j.diagmicrobio.2024.116239.

Bordetella pertussis is a bacterial pathogen responsible for pertussis, which is a highly contagious respiratory disease. Despite the relatively high vaccination coverage, pertussis is considered a re-emerging disease that necessitates enhanced strategies for identification, prevention and control. 

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.

Latest Issues

The Power to Disrupt - Clinical Diagnostics Expo UK

15 Hatfields
16 September, 2024

Microbe Conference 2024

Crowne Plaza Hotel, Sheffield, UK
20-22 September, 2024

Cardiac Marker Dialogues: Cardiac Biomarkers in Real Time – Experiences and Opportunities

Hilton Glasgow, 1 William Street, Glasgow, Scotland, G3 8HT
26-27 September, 2024

The British Association for Cytopathology Annual Scientific Meeting

Aztec Hotel and Spa, Bristol, BS32 4TS
18 October, 2024

UK NEQAS: Navigating Quality Standards in Point of Care Testing

The Hyatt Regency Hotel, Birmingham, UK
23 October, 2024